On June 19, 2026, Victorias Chief Health Officer reported six cases of acute liver injury since January in people who used an unapproved product labelled as retatrutide, sold under names including Reta, R-10, and R-20. Investigations found abnormal liver function with transaminitis, possible raised bilirubin, and coagulopathy
Similar guidance applies to those managing foods to avoid on GLP-1 medications
Research from semaglutide weight-loss trials shows that even the 0.25mg dose can yield 2-4 pounds of weight loss in the first month for responders
Most patients will experience the effects of the medication within the first couple of weeks of administration
Sample weekly rotation schedule Because tirzepatide is once weekly, build a rotation that cycles through areas over weeks (not multiple times in a single week)
Insurance coverage for weight loss medications varies significantly